KIM-1 is overexpressed in the two most prevalent forms of RCC, clear cell RCC and papillary RCC, and is touted to become a novel non-invasive biomarker for the early diagnosis of the disease through the detection of the shed ectodomain in the urine and blood of patients7,12. This evidence concerns the gene HAVCR1 and renal cell adenocarcinoma.